Su Zhang Selected Research

human PRMT2 protein

8/2018	Arginine methyltransferase inhibitor-1 inhibits sarcoma viability in vitro and in vivo.
12/2017	Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Su Zhang Research Topics

Disease

24	Neoplasms (Cancer) 01/2022 - 09/2001
17	Edema (Dropsy) 06/2015 - 09/2008
16	Sepsis (Septicemia) 01/2022 - 09/2008
13	Inflammation (Inflammations) 11/2020 - 01/2010
9	Lung Injury 01/2022 - 09/2008
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2004
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2019
5	Infections 05/2022 - 12/2017
5	Carcinogenesis 01/2022 - 03/2004
5	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 11/2018
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2019
4	Breast Neoplasms (Breast Cancer) 10/2021 - 10/2010
4	Body Weight (Weight, Body) 04/2021 - 07/2017
4	Colitis 11/2020 - 10/2014
4	Acute Lung Injury 11/2012 - 06/2011
3	Tuberculosis (Tuberculoses) 01/2022 - 01/2020
3	Myocardial Infarction 01/2021 - 06/2008
3	Hypersensitivity (Allergy) 01/2021 - 01/2018
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2014 - 01/2013
3	Streptococcal Infections (Streptococcal Infection) 11/2012 - 06/2011
3	Pneumonia (Pneumonitis) 11/2012 - 01/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2008 - 03/2002
2	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2020
2	Proteinuria 12/2021 - 01/2021
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2018
2	Hyperalgesia 04/2020 - 01/2014
2	Hypertension (High Blood Pressure) 01/2020 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 09/2016
2	Pathologic Constriction (Stenosis) 09/2019 - 01/2018
2	Hyperglycemia 01/2018 - 07/2017
2	Obesity 04/2017 - 03/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 02/2013
2	Carcinoma (Carcinomatosis) 01/2016 - 01/2016
2	Pancreatitis 09/2013 - 05/2011
1	Open Fractures (Compound Fracture) 05/2022
1	Huntington Disease (Huntington's Disease) 03/2022
1	Chorea (Rheumatic Chorea) 03/2022
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2022
1	Splenomegaly 12/2021
1	Pulmonary Embolism 12/2021
1	Ductal Carcinoma 10/2021

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 10/2020 - 10/2008
15	CXC ChemokinesIBA 02/2018 - 09/2008
6	Pharmaceutical PreparationsIBA 01/2022 - 09/2001
5	Messenger RNA (mRNA)IBA 01/2022 - 08/2013
5	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2016
4	Interleukin-6 (Interleukin 6)IBA 02/2018 - 11/2012
4	ChemokinesIBA 02/2016 - 08/2013
4	rho-Associated KinasesIBA 05/2015 - 01/2012
4	Peroxidase (Myeloperoxidase)IBA 06/2012 - 09/2008
3	Immunoglobulin E (IgE)IBA 01/2021 - 01/2018
3	Thrombin FDA Link 02/2018 - 10/2014
3	MatrinesIBA 12/2014 - 01/2013
3	Simvastatin (Zocor)FDA LinkGeneric 11/2012 - 05/2011
3	CD40 Ligand (CD40L)IBA 06/2012 - 11/2009
2	Peptides (Polypeptides)IBA 05/2022 - 01/2022
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 11/2018
2	Hormones (Hormone)IBA 01/2022 - 01/2021
2	LipidsIBA 12/2021 - 09/2019
2	Blood Glucose (Blood Sugar)IBA 04/2021 - 04/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2016
2	NAD (NADH)IBA 01/2021 - 04/2020
2	IronIBA 01/2020 - 09/2016
2	MicroRNAs (MicroRNA)IBA 01/2019 - 09/2018
2	human PRMT2 proteinIBA 08/2018 - 12/2017
2	AlbuminsIBA 01/2018 - 07/2017
2	p38 Mitogen-Activated Protein KinasesIBA 01/2018 - 01/2012
2	Dextrans (Dextran)FDA Link 06/2017 - 02/2016
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 06/2017 - 02/2016
2	CytokinesIBA 09/2016 - 04/2009
2	CreatinineIBA 01/2016 - 02/2008
2	Blood Coagulation Factors (Coagulation Factor)IBA 05/2015 - 10/2014
2	Y 27632IBA 05/2015 - 05/2012
2	Quinolizidine AlkaloidsIBA 02/2014 - 01/2013
2	Taurocholic Acid (Sodium Taurocholate)IBA 09/2013 - 05/2011
2	NSC 23766IBA 08/2013 - 01/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2012 - 05/2011
2	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 05/2011 - 09/2008
1	TitaniumIBA 05/2022
1	Tetrabenazine (Nitoman)FDA Link 03/2022
1	deutetrabenazineIBA 03/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022
1	human KISS1 proteinIBA 01/2022
1	XMD 8-92IBA 01/2022
1	Aldehyde DehydrogenaseIBA 01/2022
1	NeuropeptidesIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	NucleotidesIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	HU 308IBA 01/2022
1	Hepatocyte Nuclear FactorsIBA 01/2022
1	KisspeptinsIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021
1	fibrin fragment D (D-dimer)IBA 12/2021

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2012
8	Punctures 02/2018 - 09/2008
8	Ligation 02/2018 - 09/2008
4	Drug Therapy (Chemotherapy) 10/2021 - 01/2019
2	Lymph Node Excision (Lymph Node Dissection) 10/2021 - 09/2016
1	Cesarean Section (Caesarean Section) 12/2021